VYOME HOLDINGS, INC. Other Noncash Income (Expense)
VYOME HOLDINGS, INC. (HIND) reported Other Noncash Income (Expense) of $14.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2025-08-14
- VYOME HOLDINGS, INC. other noncash income (expense) for the quarter ending 2025-06-30 was $5.00K.
- VYOME HOLDINGS, INC. other noncash income (expense) for the quarter ending 2025-03-31 was $9.00K.
- VYOME HOLDINGS, INC. other noncash income (expense) for the quarter ending 2024-12-31 was $9.00K.
- VYOME HOLDINGS, INC. other noncash income (expense) for the quarter ending 2024-09-30 was $0.00.
- VYOME HOLDINGS, INC. other noncash income (expense) for fiscal 2024 was $7.00K.
- VYOME HOLDINGS, INC. other noncash income (expense) for fiscal 2023 was -$17.00K, a 173.91% decline from fiscal 2022.
- VYOME HOLDINGS, INC. other noncash income (expense) for fiscal 2022 was $23.00K.
- VYOME HOLDINGS, INC. other noncash income (expense) for fiscal 2020 was -$21.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2025-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $14.00K 10-Q · filed 2025-08-14 | $23.00K derived: sum of 3 quarters · filed 2025-08-14 | $23.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | $9.00K 10-Q · filed 2025-05-20 | $18.00K derived: sum of 2 quarters · filed 2025-05-20 | $18.00K derived: sum of 3 quarters · filed 2025-05-20 | $17.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $9.00K derived: sum of 2 quarters · filed 2025-04-04 | $8.00K derived: sum of 3 quarters · filed 2025-08-14 | $7.00K 10-K · filed 2025-04-04 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.00K derived: sum of 2 quarters · filed 2025-08-14 | -$2.00K 10-Q · filed 2024-11-14 | -$7.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$2.00K 10-Q · filed 2025-08-14 | -$7.00K derived: sum of 3 quarters · filed 2025-08-14 | -$7.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$1.00K 10-Q · filed 2025-05-20 | -$6.00K derived: sum of 2 quarters · filed 2025-05-20 | -$6.00K derived: sum of 3 quarters · filed 2025-05-20 | -$15.00K derived: sum of 4 quarters · filed 2025-05-20 |
| 2023-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | -$5.00K derived: sum of 2 quarters · filed 2025-04-04 | -$14.00K derived: sum of 3 quarters · filed 2025-04-04 | -$17.00K 10-K · filed 2025-04-04 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$9.00K derived: sum of 2 quarters · filed 2024-11-14 | -$12.00K 10-Q · filed 2024-11-14 | -$10.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$12.00K 10-Q · filed 2024-08-14 | -$10.00K derived: sum of 3 quarters · filed 2024-08-14 | -$7.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$3.00K 10-Q · filed 2024-05-15 | -$1.00K derived: sum of 2 quarters · filed 2024-05-15 | $2.00K derived: sum of 3 quarters · filed 2024-05-15 | $0.00 derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $5.00K derived: sum of 2 quarters · filed 2024-04-01 | $3.00K derived: sum of 3 quarters · filed 2024-04-01 | $23.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.00K derived: sum of 2 quarters · filed 2023-11-09 | $21.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $18.00K 10-Q · filed 2023-08-07 | ||
| 2022-03-31 | $20.00K 10-Q · filed 2023-05-15 | |||
| 2021-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $5.00K derived: sum of 2 quarters · filed 2022-11-14 | -$12.00K 10-Q · filed 2022-11-14 | -$12.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | -$15.00K 10-Q · filed 2022-08-19 | -$15.00K derived: sum of 3 quarters · filed 2022-08-19 | -$16.00K derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-03-31 | -$17.00K 10-Q · filed 2022-05-23 | -$17.00K derived: sum of 2 quarters · filed 2022-05-23 | -$18.00K derived: sum of 3 quarters · filed 2022-05-23 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | -$1.00K derived: sum of 2 quarters · filed 2022-04-08 | -$21.00K 10-K · filed 2022-04-08 | |
| 2020-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$21.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$20.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |